EPISODE · Jun 29, 2026 · 1H 1M
Ep. 97 - What you Really need to know about peptides with Dr. Leigh Baxt
from The Balanced Bodies Blueprint
In this episode, we cut through the hype surrounding one of the fastest-growing trends in health and fitness: peptides. Joining us is Dr. Leigh Baxt, a translational scientist with experience advancing more than 30 therapeutic programs across oncology, metabolic disease, infectious disease, and regenerative medicine. Drawing on her background at Brown University, Stanford University School of Medicine, and Harvard Medical School, Dr. Baxt explains how drugs move from promising laboratory discoveries to proven human therapies, and why that process matters. We explore why peptides have become so popular, how social media has outpaced the science, and what people often misunderstand about anecdotal success stories, animal research, and theoretical mechanisms. We also discuss why many compounds that appear promising early in development never become approved treatments, the biological risks of manipulating growth and repair pathways, and where commonly discussed peptides like BPC-157, TB-500, MOTS-C, and KPV currently stand from an evidence perspective. Finally, we tackle some of the biggest misconceptions surrounding Big Pharma, patentability, regulation, and what consumers should expect as peptide oversight continues to evolve. Whether you're considering peptides yourself or simply want to separate scientific evidence from internet marketing, this episode provides the framework needed to evaluate the claims you're seeing online. Coach VinnyEmail: [email protected]: vinnyrusso_balancedbodiesFacebook: Vinny Russo Dr. ErynEmail: [email protected]: dr.eryn_balancedbodiesFacebook: Eryn Stansfield Dr. Leigh BaxtEmail: [email protected] Instagram: sciencemomscicommLeigh collaborates heavily with unbiased science: https://www.unbiasedscience.com/ LEGION 20% OFF CODEGo to https://legionathletics.com/ and use the code RUSSO for 20% off your order!
What this episode covers
In this episode, we cut through the hype surrounding one of the fastest-growing trends in health and fitness: peptides. Joining us is Dr. Leigh Baxt, a translational scientist with experience advancing more than 30 therapeutic programs across oncology, metabolic disease, infectious disease, and regenerative medicine. Drawing on her background at Brown University, Stanford University School of Medicine, and Harvard Medical School, Dr. Baxt explains how drugs move from promising laboratory discoveries to proven human therapies, and why that process matters. We explore why peptides have become so popular, how social media has outpaced the science, and what people often misunderstand about anecdotal success stories, animal research, and theoretical mechanisms. We also discuss why many compounds that appear promising early in development never become approved treatments, the biological risks of manipulating growth and repair pathways, and where commonly discussed peptides like BPC-157, TB-500, MOTS-C, and KPV currently stand from an evidence perspective. Finally, we tackle some of the biggest misconceptions surrounding Big Pharma, patentability, regulation, and what consumers should expect as peptide oversight continues to evolve. Whether you're considering peptides yourself or simply want to separate scientific evidence from internet marketing, this episode provides the framework needed to evaluate the claims you're seeing online. Coach VinnyEmail: [email protected]: vinnyrusso_balancedbodiesFacebook: Vinny Russo Dr. ErynEmail: [email protected]: dr.eryn_balancedbodiesFacebook: Eryn Stansfield Dr. Leigh BaxtEmail: [email protected] Instagram: sciencemomscicommLeigh collaborates heavily with unbiased science: https://www.unbiasedscience.com/ LEGION 20% OFF CODEGo to https://legionathletics.com/ and use the code RUSSO for 20% off your order!
NOW PLAYING
Ep. 97 - What you Really need to know about peptides with Dr. Leigh Baxt
No transcript for this episode yet
Similar Episodes
Dec 5, 2025 ·50m
Oct 9, 2025 ·33m
Oct 3, 2025 ·40m
Sep 11, 2025 ·31m
Aug 27, 2025 ·39m
Aug 18, 2025 ·54m